Search

everythinglearnresearchcommunity

for

Search:↓

Thermus thermophilus extract improves hair growth and scalp health in men with hair loss.

The drug TGU was ineffective against small cell lung cancer and caused significant bone marrow suppression.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Topical tacalcitol can treat psoriasis by acting directly on skin cells.

Teprotumumab for thyroid eye disease commonly causes fatigue, brittle nails, dry eyes, hair loss, muscle spasms, and dry mouth, with rare serious events like blood clots.

TECAR therapy helps with pain relief, reduces inflammation, relaxes muscles, heals tissues, and is safe and effective for many conditions.

TPA promotes hair growth by increasing stem cell activity and activating specific cell signals.

HOTTIP and miR-10b contribute to glioma therapy resistance by affecting cell behavior, suggesting they could be targets for treatment.

Temozolomide improves survival in grade III glioma patients without harming quality of life.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

Low free thyroxine (FT4) is common in young lupus patients and needs quick diagnosis and treatment.

High levels of ST14 and TMEFF1 proteins in ovarian cancer are linked to worse patient outcomes and may be a new treatment target.

Tofacitinib may help treat severe hair loss, but more research is needed.

Treg dysfunction is linked to various autoimmune skin diseases, and understanding Treg properties is key for new treatments.

Tofacitinib helped a 19-year-old regrow hair after other treatments failed.

The patient with autoimmune hypothyroidism improved after treatment for thyroid and associated conditions.

Some patients on anti-TNF drugs experience a type of hair loss called TAIAPA.

Dihydrotestosterone has a reduced effect on muscle-building in people with testicular feminization syndrome, especially after their gonads are removed.

Tofacitinib can regrow hair in alopecia areata patients, but some may experience flares during treatment.

The registry showed that tofacitinib is promising for treating hair loss in children with alopecia areata, but more research is needed.

Troglitazone increases subcutaneous fat in lipodystrophy patients.

CTP-543 significantly improved eyebrow and eyelash regrowth and patient satisfaction in adults with alopecia areata.

TRPV4 helps cells repair tissue and reduce scarring by controlling calcium levels.

Enhancing Tregs can protect against alopecia areata.

Tofacitinib is effective and safe for treating severe hair loss in Korean patients.

The study found that Tourette Syndrome may be linked to certain immune system processes and synaptic signaling.

The Labrador dog fully recovered from hypothyroidism after 3 months of treatment.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.